Developmental exposure to the antiretroviral drug zidovudine increases brain levels of brain-derived neurotrophic factor in mice

Neuroscience Letters

Volumn 333, Issue 2, 2002, Pages 111-114

  Calamandrei, Gemma ^a   Valanzano, Angela ^a   Puopolo, Maria ^a   Aloe, Luigi ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b CNR   (Italy)

Author keywords

Brain derived neurotrophic factor; Mouse; Nerve growth factor; Neurodevelopment; Zidovudine

Indexed keywords

ANTIRETROVIRUS AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; DRUG VEHICLE; NERVE GROWTH FACTOR; ZIDOVUDINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEVELOPMENT; DOSE CALCULATION; DRUG EXPOSURE; ENZYME IMMUNOASSAY; FEMALE; HIPPOCAMPUS; HYPOTHALAMUS; LACTATION; MALE; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEWBORN; NONHUMAN; PERINATAL PERIOD; PREGNANCY; PRENATAL PERIOD; PRIORITY JOURNAL; PROGENY; PROTEIN CONTENT; PROTEIN DETERMINATION;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; ANTIMETABOLITES; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; MALE; MICE; NERVE GROWTH FACTOR; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SEX FACTORS; TIME FACTORS; ZIDOVUDINE;

EID: 0037159583     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)01023-6     Document Type: Article

References (20)

1. Alleva E., Calamandrei G. Polypeptide growth factors in mammalian development: some issues for neurotoxicology and behavioural teratology. Neurotoxicology. 11:1990;293-304.
2. Arenas E., Akerud P., Wong V., Boylan C., Persson H., Lindsay R.M., Altar C.A. Effects of BDNF and NT-4/5 on striatonigral neuropeptides or nigral GABA neurons in vivo. Eur. J. Neurosci. 8:1996;1707-1717.
3. Blanche S., Tardieu M., Rustin P., Slama A., Barret B., Firtion G., Ciraru-Vigneron N., Lacroix C., Rouzioux C., Mandelbrot L., Desguerre I., Rotig A., Mayaux M.J., Delfraissy J.F. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet. 354:1999;1084-1089.
4. Brinkman K., Hadewych J.M., Burger D.M., Smetink J.A.M., Koopmans P.P. Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS. 12:1998;1735-1744.
5. Busidan Y., Dow-Edwards D.L. Neurobehavioral effects of perinatal AZT exposure in Sprague-Dawley adult rats. Neurotoxicol. Teratol. 21:1999;359-363.
6. Calamandrei G., Venerosi A., Branchi I., Chiarotti F., Verdina A., Bucci F., Alleva E. Effects of prenatal AZT on mouse neurobehavioral development and passive avoidance learning. Neurotoxicol. Teratol. 21:1999;29-40.
7. Connor E.M., Sperling R.S., Gelber R., Kiselev P., Scott G., O'Sullivan M.J., VanDyke R., Bey M., Shearer W., Jacobson R.L., Jimenez E., O'Neill E., Bazin B., Delfraissy J.F., Culnane M., Coombs R., Elkins M., Moye J., Stratton P., Balsley J. Reduction of maternal-infant trasmission of human immunodeficiency virus type 1 with zidovudine treatment. N. Engl. J. Med. 331:1994;1173-1180.
8. Fiore M., Aloe L., Westenbroek C., Amendola T., Antonelli A., Korf J. Bromodeoxyuridine and methylazoxymethanol exposure during brain development affects behavior in rats: consideration for a role of nerve growth factor and brain derived neurotrophic factor. Neurosci. Lett. 309:2001;113-116.
9. Gwag B.J., Koh J.Y., Chen M.M., Dugan L.L., Behrens M.M., Lobner D., Choi D.W. BDNF or IGF-I potentiates free radical-mediated injury in cortical cell cultures. NeuroReport. 7:1995;93-96.
10. Heaton M.B., Mitchell J.J., Paiva M., Walker D.W. Ethanol-induced alterations in the expression of neurotrophic factors in the developing rat central nervous system. Dev. Brain Res. 121:2000;97-107.
11. Hyman C., Hofer M., Barde Y.A., Juhasz M., Yancopoulos G.D., Squinto S.P., Lindsay R.M. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature. 350:1991;230-232.
12. Katoh-Semba R., Takeuchi I.K., Semba R., Kato K. Distribution of brain-derived neurotrophic factor in rats and its changes with development in the brain. J. Neurochem. 69:1997;34-42.
13. Kellogg C.K., Yao J., Pleger G.L. Sex-specific effects of in utero manipulation of GABA(A) receptors on pre- and postnatal expression of BDNF in rats. Dev. Brain Res. 121:2000;157-167.
14. Landreau-Mascaro A., Barret B., Mayaux M.J., Tardieu M., Blanche S. Risk of early febrile seizure with perinatal exposure to nucleoside analogues. Lancet. 359:2002;583-584.
15. Ricceri L., Venerosi A., Valanzano A., Sorace A., Alleva E. Prenatal AZT or 3TC and mouse development of locomotor activity and hot-plate responding upon administration of the GABA(A) receptor agonist muscimol. Psychopharmacology. 153:2001;434-442.
16. Tandon P., Yang Y., Das K., Holmes G.L., Stafstrom C.E. Neuroprotective effects of brain-derived neurotrophic factor in seizures during development. Neuroscience. 91:1999;293-303.
17. Venero J.L., Knusel B., Beck K.D., Hefti F. Expression of neurotrophin and trk receptor genes in adult rats with fimbria transections: effect of intraventricular nerve growth factor and brain-derived neurotrophic factor administration. Neuroscience. 59:1994;797-815.
18. Venerosi A., Cirulli F., Lil'p I.G., Fiore M., Calamandrei G., Alleva E. Prolonged perinatal exposure to AZT affects aggressive behavior of adult CD-1 mice. Psychopharmacology. 150:2000;404-411.
19. Weskamp G., Otten U. An enzyme-linked immunoassay for nerve growth factor (NGF): a tool for studying regulatory mechanisms involved in NGF production in brain and in peripheral tissues. J. Neurochem. 48:1987;1779-1786.
20. Zhou J., Pliego-Rovero B., Bradford H.F., Stern G.M. The BDNF content of postnatal and adult rat brain: the effects of 6-hydroxydopamine lesions in adult brain. Dev. Brain Res. 97:1996;297-303.